Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05904-z
Abstract: Background Golimumab is a new anti-TNF-alpha monoclonal antibody for patients with ulcerative colitis. Aims To assess the short- and long-term effectiveness and safety of golimumab in daily clinical practice and to identify predictors of response.… read more here.
Keywords: safety golimumab; ulcerative colitis; response; patients ulcerative ... See more keywords